Menu

First fibrotic disease drug of Singapore advances into Phase II clinical evaluation

Article |

fiercequartz 1mo ago
First fibrotic disease drug of Singapore advances into Phase II clinical evaluation

Duke-NUS Medical School in Singapore has noted the announcement by Boehringer Ingelheim of a Phase IIa clinical study evaluating BI 765423,...

Comments (0)

Newest

No comments yet.